Involvement of vagal opioid receptors in respiratory effects of morphine in anaesthetized rats

Journal of Physiology and Pharmacology

Volumn 56, Issue 2, 2005, Pages 195-203

  Kaczynska K ^a   Szereda Przestaszewska, M ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Control of breathing; Morphine; Opioid receptors; Rat; Vagus nerve

Indexed keywords

CHLORALOSE; MORPHINE; NALOXONE; OPIATE RECEPTOR; URETHAN;

ADOLESCENT; ANESTHESIA; APNEA; ARTICLE; BOLUS INJECTION; BREATHING RATE; CONTROLLED STUDY; DRUG EFFECT; EXHALATION; EXPIRATORY TIME; FEMORAL VEIN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RESPIRATION CONTROL; RESPIRATION DEPRESSION; RESPIRATORY SYSTEM; TIDAL VOLUME; VAGOTOMY; VAGUS NERVE;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; RATS; RATS, WISTAR; RECEPTORS, OPIOID; RESPIRATION; VAGUS NERVE;

EID: 21344432565     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Martin BJ, Zwillich CW, Weil JV. Morphine reduces ventilation without changing metabolic rate. Med Sci Sports Exerci 1980; 12: 285-287
2. Daykin AP, Bowen DJ, Saunders DA, Norman J. Respiratory depression after morphine in the elderly. A comparison with younger subjects. Anaesthesia 1986; 41: 910-914
3. Santiago TV, Teodoro V, Edelman NH. Opioids and breathing. J Appl Physiol 1985; 59: 1675-1685
4. Kokka N, Eliott HW, Way EL. Some effects of morphine on respiration and metabolism of rats. J Pharmacol Exp Therap 1965; 148: 386-392
5. McGilliard KL, Takemori AE. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J Pharmacol Exp Ther 1973; 207: 494-503
6. Morin-Surun MP, Boudinot E, Gacel G, Champagnat J, Roques BP, Denavit-Saubie M. Different effects of μ and δ opiate agonists on respiration. Eur J Pharmacol 1984; 98: 235-240
7. Pelligrino DA, Peterson RD, Henderson SK, Albrecht RF. Comparative ventilatory effects of intravenous versus fourth cerebroventricular infusions of morphine sulfate in the unanaesthetized dog. Anesthesiol 1989; 71: 250-259
8. Pelligrino DA, Laurito CE, VadeBoncouer TR. Nitric oxide synthase modulates the ventilatory depressant and antinociceptive actions of fourth ventricular infusions in the awake dog. Anesthesiol 1996; 85: 1367-1377
9. McQueen DS. Opioid peptide interactions with respiratory and circulatory systems. Br Med Bull 1983; 39: 77-82
10. Sales N, Riche D, Roques BP, Denavit-Saubie M. Localization of mu and delta opioid receptors in cat respiratory areas: an autoradiographic study. Brain Res 1985; 344: 382-386
11. Nomura S, Ding YQ, Kaneko T, Li JL, Mizuno N. Localization of mu-opioid receptor-like mmunoreactivity in the central components of the vagus nerve: a light and electron microscope study in the rat. Neurosci 1996; 73: 277-286
12. Ding YQ, Li JL, Lu BZ, Wang D, Zhang ML, Li JS. Co-localization of mu-opioid receptor- like immunoreactivity with substanceP-LI, calcitonin gene-related peptide-LI and nitric oxide synthase-LI in vagal and glossopharyngeal afferent neurons of the rat. Brain Res 1998; 792: 149-153
13. Zarbin MA, Wamsley JK, Kuhar MJ. Anterograde transport of opioid receptors in rat vagus nerves and dorsal roots of spinal nerves: pharmacology and sensitivity to sodium and guanine nucleotides. Exp Brain Res 1990; 81: 267-278
14. Li J-L, Kaneko T, Mizuno N. Effects of peripheral nerve ligation on expression of μ-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion of the rat. Neurosci Lett 1996; 214: 91-94
15. Willette RN, Sapru HN. Pulmonary opiate receptor activation evokes a cardiorespiratory reflex: Eur J Pharmacol 1982; 78: 61-70
16. Willette RN, Sapru HN. Peripheral versus central cardiorespiratory effects of morphine. Neuropharmacol 1982; 21: 1019-1026
17. Hoogen van den RHWM, Colpaert FC. Respiratory effects of morphine in awake unrestrained rats. J Pharmacol Exp Ther 1985; 237: 252-259
18. Hoffmann LH, Vermeyen KM, Adriaensen HF, Meert TF. Effects of NMDA receptor antagonists on opioid-induced respiratory depression and acute antinociception in rats. Pharmacol Biochem Behav 2003; 74: 933-941
19. Willette RN, Krieger AJ, Sapru HN. Opioids increase laryngeal resistance and motoneuron activity in the recurrent laryngeal nerve. Eur J Pharmacol 1982; 80: 57-63
20. Willette RN, Barcas PP, Krieger AJ, Sapru HN. Pulmonary resistance and compliance changes evoked by pulmonary opiate receptor stimulation. Eur J Pharmacol 1983; 91: 181-188
21. Wu D, Kang VS, Bickel V, Partridge WM. Blood-brain permeability to moiphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 1997; 25: 768-771
22. Hurlé MA, Mediavilla A, Flórez J. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects. J Pharmacol Exp Ther 1982; 220: 642-647
23. Holaday JW. Cardiorespiratory effects of mu and delta opiate agonists following third or fourth ventricular injection. Peptides 1982; 3: 1023-1029
24. Colman AS, Miller JH. Modulation of breathing by μ1 and μ2 opioid receptor stimulation in neonatal and adult rats. Respir Physiol 2001; 127: 157-172
25. Holaday JW, Pasternak GW, Faden AI. Naloxazone pretreatment modifies cardiorespiratory, temperature, and behavioral effects of morphine. Neurosci Lett 1983; 37: 199-204
26. Randich A, Thurston CL, Ludwig PS, Timmerman MR, Gebhart GF. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents. Brain Res 1991; 543: 256-270
27. Fennessy MR, Rattray JF. Cardiovascular effects of intravenous morphine in the anaesthetized rat. Eur J Pharmacol 1971; 14: 1-8
28. Bellet M, Elghozi JL, Meyer P, Pernollet MG, Schmitt H. Central cardiovascular effects of narcotic analgesics and enkephalins in rats. Br J Pharmacol 1980; 71: 365-369